Friday 6 November 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024.

Revenue: +30.2%
EPS: −22.3%
Free cash flow: +137.8%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

300.31 0.06 +0.02%

Follow KRYS

Alert me

Market cap: $8.9B
P/E: 39.2×
Fwd P/E: 45.7×
Dividend yield: —
F-score: 7/9
Altman Z: 39.03
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	43.42	44.94	33.33	34.82	+8 more quarters Free account
P/S ratio Full definition →	20.95	24.92	18.13	18.34
P/FCF ratio Full definition →	31.76	42.57	31.87	37.69
P/Operating CF Full definition →	107.91	146.75	94.12	92.07
P/B ratio Full definition →	6.86	8.08	5.93	5.85
Price to Tangible BV Full definition →	6.86	8.08	5.93	5.85
EV/Sales Full definition →	19.01	23.00	16.16	16.21
EV/EBITDA Full definition →	38.14	49.55	36.37	37.58
EV/Operating CF Full definition →	27.58	37.19	26.94	31.40
EV/FCF Full definition →	28.82	39.29	28.40	33.31
Quick Ratio Full definition →	7.35	7.73	8.82	9.28
Current Ratio Full definition →	7.89	8.32	9.46	9.95
Net Debt/EBITDA Full definition →	(12.52)	(14.10)	(14.86)	(17.98)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.33	0.33	0.34	0.33
Operating CF/Net income Full definition →	1.45	1.37	1.44	1.51
Capex/Depreciation Full definition →	(0.59)	(2.28)	(4.14)	(1.21)
Research and Development Expense of Revenue Full definition →	11.69%	12.18%	13.18%	13.81%
Selling, General and Administrative Expense of Revenue Full definition →	26.50%	33.43%	35.25%	38.70%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	10.95%	11.87%	11.70%	12.85%
Graham Net Nets Full definition →	0.10	0.08	0.12	0.13
Graham Number Full definition →	91.41	92.54	87.19	81.93
Earnings Yield Full definition →	2.30%	2.23%	3.00%	2.87%
Free Cash Flow Yield Full definition →	3.15%	2.35%	3.14%	2.65%
Revenue per Share Full definition →	4.30	4.04	3.97	3.70
Operating CF per Share Full definition →	3.08	2.53	2.74	2.68
Capex per Share Full definition →	(0.03)	(0.12)	(0.24)	(0.07)
Free Cash Flow per Share Full definition →	3.05	2.41	2.50	2.60
Cash per Share Full definition →	30.80	28.64	28.11	28.60
Shareholders Equity per Share Full definition →	48.48	46.03	43.59	42.14
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	48.48	46.03	43.59	42.14
Free Cash Flow Full definition →	90.25	71.22	73.23	75.37
Working Capital Full definition →	979.62	932.25	911.94	921.66
Capital Expenditures Full definition →	(1.00)	(3.56)	(7.15)	(2.14)
Net Current Asset Value Full definition →	971.29	918.13	899.50	910.37
EV/EBIT Full definition →	39.27	51.22	37.72	39.11
Capex to Sales Full definition →	0.01	0.03	0.06	0.02
Price to Operating Income Full definition →	43.28	55.50	42.33	44.24
Other line items
Average Receivables Full definition →	131.37	125.05	115.14	116.09
Average Payables Full definition →	4.41	6.83	3.38	4.11
Average Inventory Full definition →	44.21	38.30	36.29	33.49
Average Assets Full definition →	1,413.08	1,319.52	1,235.69	1,194.82
Average Common Equity Full definition →	1,286.73	1,199.89	1,130.70	1,082.97

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly